首页> 外文期刊>Drug testing and analysis >Synthesis and identification of deschloroketamine metabolites in rats' urine and a quantification method for deschloroketamine and metabolites in rats' serum and brain tissue using liquid chromatography tandem mass spectrometry
【24h】

Synthesis and identification of deschloroketamine metabolites in rats' urine and a quantification method for deschloroketamine and metabolites in rats' serum and brain tissue using liquid chromatography tandem mass spectrometry

机译:用液相色谱法串联质谱法测定大鼠尿液中脱硫和脑组织代谢产物的脱氯胺代谢物的合成与鉴定。

获取原文
获取原文并翻译 | 示例
       

摘要

Deschloroketamine (2-(methylamino)-2-phenyl-cyclohexanone) is a ketamine analog belonging to a group of dissociative anesthetics, which have been distributed within the illicit market since 2015. However, it was also being sold as 'ketamine' misleading people to believe that they were getting genuine ketamine. Dissociative anesthetics have also come to the attention of the psychiatric field due to their potential properties in the treatment of depression. At present, there is a dearth of information on deschloroketamine related to its metabolism, biodistribution, and its mechanism of action. We have therefore carried out a metabolomics study for deschloroketamine via non-targeted screening of urine samples employing liquid chromatography combined with high-resolution mass spectrometry. We developed and validated a multiple reaction monitoring method using a triple quadrupole instrument to track metabolites of deschloroketamine. Furthermore, significant metabolites of deschloroketamine, (trans-dihydrodeschloroketamine, cis- and trans-dihydronordeschloroketamine, and nordeschloroketamine), were synthesized in-house. The prepared standards were utilized in the developed multiple reaction monitoring method. The quantification method for serum samples provided intra-day accuracy ranging from 86% to 112% with precision of 3% on average. The concentrations of cis/trans-dihydronordeschloroketamines and trans-dihydrodeschloroketamine were lower than 10 ng/mL, nordeschloroketamine and deschloroketamine ranged from 0.5 to 860 ng/mL in real samples. The quantification method for brain tissue provided intra-day accuracy ranging from 80% to 125% with precision of 7% on average. The concentrations of cis/trans-dihydronordeschloroketamines and trans-dihydrodeschloroketamine ranged from 0.5 to 70 ng/g, nordeschloroketamine and deschloroketamine varied from 0.5 to 4700 ng/g in real samples.
机译:脱氯甲胺(2-(甲基氨基)-2-苯基 - 环己酮)是属于一组分离麻醉剂的氯胺酮类似物,该麻痹麻醉剂已自2015年以来已在非法市场中分发。然而,它也被销售为“氯胺酮”误导性的人相信他们正在得到真正的氯胺酮。分离麻醉剂也因其在抑郁症治疗中的潜在特性而引起精神病田的注意。目前,有一种关于与其新陈代谢,生物分布的脱氯胺的缺乏信息,以及其作用机制。因此,我们已经通过使用液相色谱法与高分辨率质谱相结合的尿液样品进行脱氯替胺进行代谢氯胺类研究。我们开发并验证了一种使用三重四极仪探测多重反应监测方法,以跟踪Deschorroketamine的代谢物。此外,在室内合成了脱氯甲胺,(反式二氢氯氯丙胺,CIS-和反式二氢氯丙醇氯替胺和NordeSchoroketamine)的显着代谢产物。在开发的多反应监测方法中使用制备的标准。血清样品的定量方法提供了在日内精度范围为86%至112%,平均精度为3%。 CIS /反式二氢氯氯丙胺和反式二氢氯替胺的浓度低于10ng / ml,NordeSchloketamine和Deschorro甲胺在真实样品中的0.5至860ng / ml。脑组织的定量方法提供了日内精度从80%到125%,平均精度为7%。 CIS /反式二氢二氯丙酮和反式二氢氯替胺的浓度范围为0.5至70ng / g,NordeSchloroketamine和Deschorro戊胺在真实样品中的0.5至4700ng / g之间变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号